IMATINIB MESYLATE
- Product NDC
- 63629-2068
- 11-digit product format
- 636292068
- Labeler code
- 63629
- Product ID
- 63629-2068_dd41d8b0-59fb-49b8-8001-34a9f5a9144a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IMATINIB MESYLATE
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA205990
- Marketing category
- ANDA
- Marketing start
- 2019-02-08
- Marketing end
- 2023-06-30
- Substance
- IMATINIB MESYLATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-2068-1 | 63629206801 | 30 TABLET, COATED in 1 BOTTLE (63629-2068-1) | 2021-02-04 | 0000-00-00 | No | No | Current |